Teneligliptin Hydrobromide Teneligliptin HBr CAS 906093-29-6 CAS 906093-29-6 Munditia >99.5% (HPLC) DPP-4
Copia Teneligliptin Hydrobromide Related media Cum High Munditia
Teneligliptin Hydrobromide CAS 906093-29-6
1-(3-Methyl-1-Phenyl-5-Pyrazolyl)piperazinum CAS 401566-79-8
Teneligliptin Hydrobromide Intermediate CAS 401564-36-1
| Nomen chemicum | Teneligliptin Hydrobromide |
| Synonyma | Teneligliptin HBr |
| CAS Number | 906093-29-6 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C22H32.5N6OSBr2.5 |
| M. Pondus | 628.86 |
| Brand | Ruifu Chemical |
| Items | Standards | Results |
| Cnotis | Alba vel Off-White pulveris | Obsequitur |
| Identification | per IR | Obsequitur |
| per HPLC | Obsequitur | |
| Aqua Content (KF) | <6.00% | 3.00% |
| Residue onegognition | <0.50% | 0.10% |
| HeavyMetals (ut Pb) | <20ppm | Obsequitur |
| Substantiae cognatae | Ulla immunitas: <0.10% | 0.05% |
| Totalis immunditias: <0.50% | 0.15% | |
| Puritas / Analysis Methodus | >99.5% (by HPLC) | 99.85% |
| Assay | 99.5%~ 102.0% (Anhydrous substantia) | 99.90% |
| Test Standard | Enterprise Standard | |
| conclusio | ProductumCompliedtoIn-DomusStandard. | |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Teneligliptin hydrobromideum (CAS: 906093-29-6) dipeptidylum peptidase-4 (DPP-4) inhibitor, qui genus diabete tractandi adhibetur.Per excretionem eximitur, et dimidiae vitae 24.2 horas in corpore humano habet.Teneligliptin est inhibitor DPP-4, qui in Iaponia anno 2012 probatus est ad tractationem speciei II diabete.Inventa et evoluta a Mitsubishi Tanabe Pharma sub artis nomine Tenelia®.Similia aliis inhibitoribus venalibus DPP-4, teneligliptin in omnibus studiis bene toleratum fuit et QD dosing actionem inhibendi contra DPP-4 produxit diuturnam et incrementum in gradus activorum GLP-1, cum infimae rates excretionis renalis.
